The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis

New England Journal of Medicine

Volumn 342, Issue 14, 2000, Pages 1007-1014

  Van Jaarsveld, Brigit C ^a,g   Krijnen, Pieta ^b   Pieterman, Herman ^a   Derkx, Frans H M ^a   Deinum, Jaap ^a   Postma, Cornelis T ^c   Dees, Ad ^d   Woittiez, Arend J J ^e   Bartelink, Anton K M ^f   In 'T Veld, Arie J Man ^a   Schalekamp, Maarten A D H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d IKAZIA HOSPITAL   (Netherlands)

^e TWENTEBORG HOSPITAL   (Netherlands)

^f EEMLAND HOSPITAL   (Netherlands)

^g Dianet Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON; ANTIHYPERTENSIVE AGENTS; ARTERIOSCLEROSIS; BLOOD PRESSURE; CREATININE; FEMALE; HUMANS; HYPERTENSION, RENOVASCULAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL ARTERY; RENAL ARTERY OBSTRUCTION;

EID: 0034611716     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200004063421403     Document Type: Article

References (24)

1. Goldblatt H, Lynch J, Hanzal RJ, Summerville WW. Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934;59:347-79.
2. Hunt IC, Sheps SG, Harrison EG Jr, Strong CG, Bernatz PE. Renal and rcnovascular hypertension: a reasoned approach to diagnosis and management. Arch Intern Med 1974;133:988-99.
3. Foster JH, Maxwell MH, Franklin SS, et al. Renovascular occlusive disease: results of operative treatment. JAMA 1975;231:1043-8.
4. Grüntzig A, Vetter W, Meier B, Kuhlmann U, Lütolf U, Siegenthaler W, Treatment of renovascular hypertension with percutaneous transluminal dilatation of a renal-artery stenosis. Lancet 1978;1:801-2.
5. Pickering TG, Laragh JH. Renovascular hypertension. In: Brenner BM, Rector FC Jr, eds. The kidney. 4th ed. Vol. 2. Philadelphia: WB. Saunders, 1991:1940-67.
6. Ramsay LE, Waller PC. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. BMJ 1990;300:569-72.
7. Plouin PF, Chatellier G, Darné B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Hypertension 1998;31:823-9.
8. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of per cutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. J Hum Hypertens 1998;12: 329-35.
9. van Jaarsveld BC, Krijnen P, Bartelink A, et al. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale, design and inclusion data. J Hypertens Suppl 1998;16:S21-S27.
10. Zelen M. The randomization and stratification of patients to clinical trials. J Chronic Dis 1974;27:365-75.
11. American Society of Hypertension. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. Am J Hypertens 1992;5:207-9.
12. van Jaarsveld BC, Krijnen P, Derkx FHM, Oei HY, Postma CT, Schalckamp MADH. The place of renal scintigraphy in the diagnosis of renal artery stenosis: fifteen years of clinical experience. Arch Intern Med 1997;157:1226-34.
13. Fommei E, Ghione S, Hilson AJW, et al. Captopril radionuclide test in renovascular hypertension: a European multicentre study. Eur J Nucl Med 1993;20:617-23.
14. Nally JV Jr, Chen C, Fine H, et al. Diagnostic criteria of renovascular hypertension with captopril renography: a consensus statement. Am J Hypertens 1991;4:749S-752S.
15. Main principles for the establishment of Defined Daily Doses. In: Guidelines for ATC classification and DDD assignment. Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology, 1995:22-31.
16. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
17. Kremer Hovinga TK, de Jong PE, de Zeeuw D, Donker AJM, Schuur KH, van der Hem GK. Restenosis prevalence and long-term effects on renal function after percutaneous transluminal renal angioplasty. Nephron 1986;44:Suppl 1:64-7.
18. Plouin PF, Darné B, Chatellier G, et al. Restenosis after a first percutaneous transluminal renal angioplasty. Hypertension 1993;21:89-96.
19. Jensen G, Zachrisson BF, Delin K, Volkmann R, Aurell M. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int 1995;48:1936-45.
20. van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999;353:282-6.
21. Blum U, Krumme B, Flügel P, et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med 1997;336:459-65.
22. Hansen KJ, Tribble RW, Reavis SW, et al. Renal duplex sonography: evaluation of clinical utility. J Vasc Surg 1990;12:227-36.
23. Hoffmann U, Edwards JM, Carter S, et al. Role of duplex scanning for the detection of atherosclerotic renal artery disease. Kidney Int 1991; 39:1232-9.
24. Mann SJ, Pickering TG, Sos TA, et al. Captopril renography in the diagnosis of renal artery stenosis: accuracy and limitations. Am J Med 1991;90:30-40.